Aim: Neural tube defects (NTDs) are birth defects of the nervous system and are the second most frequent cause of birth defects worldwide. The etiology of NTDs is complicated and involves both genetic and environmental factors. CASP9 is an initiator caspase in the intrinsic apoptosis pathway, which in Casp9 −/− mice has been shown to result in NTDs because of decreased apoptosis. The aim of this study was to evaluate the potential genetic contribution of the CASP9 gene in human NTDs.
| INTRODUCTION
Neural tube defects (NTDs) are a group of severe birth defects of the central nervous system, which are caused by failure of neural tube closure (NTC) during embryogenesis. NTDs are the second most common birth defect in the world, affecting 0.5-2 live births per 1000, with varying prevalence in different populations. however, these individuals generally suffer from lifelong disabilities.
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The etiology of NTDs is complicated and involves both genetic and environmental factors. Epidemiological studies have revealed that folate deficiency may increase the risk of NTDs in humans, and that folic acid (FA) supplementation during periconception can reduce this risk. [3] [4] [5] [6] Although the genetic causation of human NTDs is poorly understood, studies in more than 240 mutant mouse models of NTDs provide the basis for a plausible pathological mechanism. In addition to null, hypomorphic, and conditional mutations of candidate genes in animal models of NTDs, point mutations can also lead to NTD phenotypes, 7 suggesting a possible contribution for rare variants in the etiology of human NTDs. NTC is a dynamic process in which the neural plate elevates, bends, and fuses to shape the neural tube. Therefore, the process of cell apoptosis in the correct balance is necessary for normal neural tube development. 8 Excessive apoptosis results in a lack of available cells for the formation of the neural tube; this is one of the most common phenotypes observed in animal models. 9, 10 However, live imaging studies in cultured mouse embryos have also shown that inhibition of apoptosis can increase the risk of exencephaly. 8 Caspases, the main components of the apoptotic process, are a group of proteases with essential cysteine residues in the active site that are required for substrate cleavage.
11 Caspase-9, originally discovered in Caenorhabditis elegans, is the initiator caspase of the intrinsic apoptosis pathway. This caspase functions with cytochrome c and apoptotic protease-activating factor-1 (APAF-1) to activate executioner caspase-3, subsequently triggering activation of the caspase cascade. 12 Casp9 deficiency in the 129/SvJ mouse results in abnormalities, including exencephaly in the mid-and hindbrain, and enlarged ventricular zones in the fore-and midbrain. [13] [14] [15] [16] Similarly, a lack of Apaf-1, Casp3, or cytochrome c causes ventricular zone expansion, brain overgrowth, and exencephaly, [17] [18] [19] [20] suggesting that this cascade is crucial for cranial NTC. Interestingly, a polymorphic genotype, CASP9 c.1263A>G, reduces predisposition for the risk of bladder, gastric, and colorectal cancer, while increasing the risk of lung cancer. [21] [22] [23] [24] This suggests that a genetic variant of the CASP9 gene contributes to human disease, but the impact on function can be diverse depending on the context. 
| MATERIALS AND METHODS

| Human subjects
| Genomic DNA sequencing
Genomic DNA was extracted from the human subjects using the 
| Western blotting
Cells were harvested at 24 or 48 hours after transfection and . Bands were quantified using the gray density of each band, the data were standardized to the Actin band, and then the data were normalized to corresponding WT band.
| CASP9 and CASP3 activity assays
The activities of CASP9 and CASP3 were tested using CASP9 and CASP3 activity kits (Beyotime Institute of Biotechnology). Following previously described treatments, the NE-4C and HEK293T cells were collected. The admixture included 10 μL of whole-cell protein lysate, 80 μL of reaction buffer, 10 μL of CASP9 substrate acetyl-Leu-Glu-
This was maintained in an incubator at 37°C for 20 hours and then measured via enzyme-linked immunosorbent assay (ELISA) at an absorbance of 405 nm. CASP9 and CASP3 activities were calculated based on a standard curve. These experimental processes were performed according to the manufacturer's instructions.
| Real-time quantitative PCR
HEK293T cells were transfected with WT or mutant CASP9 plasmids and harvested at 24 hours after transfection. Total RNA was isolated 
| Annexin-V and propidium iodide (PI) assays
To investigate the role of the mutants in the apoptosis of HEK293T 
| Tissue folate concentration determination
Brain tissues were collected, and the folate levels were determined using a competitive receptor binding immunoassay (Chemiluminescent Immunoenzyme Assay; Beckman Coulter). The folate concentration was analyzed, and readout was accomplished using the Access 2 Immunoassay system (Beckman Coulter). The detailed experimental processes were performed according to the manufacturer's instructions.
| Statistical analysis
In the variation rate analysis of human subjects, difference between cases and controls was evaluated by Chi-squared test, or Fisher's exact test. In the cellular experiments, statistical significance was evaluated using one-way analysis of variance (ANOVA). All results are expressed as mean ± SD. All reported P values are 2-sided, and P < 0.05 was considered statistically significant. All data statistical analysis was performed using SPSS 20.0 software.
| RESULTS
| Rare variants identified in the CASP9 gene
In 29 NTDs cases, 20 mutations were identified whereas 8 mutations were found in 8 controls (Table 1 , P = 0.027), suggesting that NTDs cases carry more CASP9 mutations than controls. The minor allele frequency was < 1%, and all rare variants were heterozygous. Figure 1A,B) . 27 Amino acid conservation analysis showed that the p.G66A and p.Y251C mutations affected highly conserved amino acid residues, while p.R173C and p.R191G mutations affected poorly conserved amino acid residues ( Figure 1C and Table 3 ). Functional prediction analysis showed that p.G66A and p.R191G were likely to be damaged by SIFT, and p.G66A, p.R173C, and p.Y251C were likely to be damaged by PolyPhen (Table 3 ). The p.K292E (c.874A>C) was a missense variant identified in controls ( Figure 1A,B) . In view of the frequency of recurrence, genomic location, conservation, and bioinformatics analysis, we focused on the 3 NTD-specific missense mutations (p.G66A, p.R191G, and p.Y251C) in the following experiments. These mutations were traced via Sanger sequencing ( Figure 1C ).
| Rare missense variants in CASP9 gene in NTDs
T 
| The p.Y251C variant-affected protein expression and CASP9 activity
Given that CASP9 is a cysteine-containing aspartate-specific protease, we addressed the question of whether the 3 rare missense variants affected protease activity. WT CASP9 and mutant plasmids tagged with Myc were constructed and transiently transfected into NE-4C cells, which is a rodent p53-deficient E9 neural ectoderm cell line. 28, 29 Because p53 plays a role upstream of CASP9 during the apoptosis process, it would be advantageous for NE-4C cells to avoid the biological impacts of p53. Western blotting assays revealed that protein levels of CASP9-tagged-Myc and pro-CASP9 in the p.Y251C variant were significantly lower than those in WT ( Figure 2A) ; this result was confirmed in another human embryonic cell line, HEK293T ( Figure 2B ). Cleaved-CASP9
(the active form) was consistently decreased in the p.Y251C variant (Figure 2A,B) . In addition, CASP9 activity in both NE-4C and HEK293T cells was 0.35-and 0.5-fold lower, respectively, than in the WT cells (P < 0.05), in contrast, CASP9 activity in the other 2 mutants was similar to the WT ( Figure 2C,D) . CASP9 mRNA levels in these variants were comparable to the levels in WT ( Figure 2E ), suggesting that protein stability of the p.Y251C variant may be impaired, and consequently, this may lead to a reduction in total CASP9 activity. Score ranges from 0 to 1; the amino acid substitution was predicted to be damaging if the score was ≤0.05 and tolerated if the score was >0.05, prediction cutoff = 0.05. e Score ranges from 0 to 1; the amino acid substitution was assessed for whether it was damaging according to the false-positive rate.
F I G U R E 1
| The p.Y251C variant impaired apoptotic function
As an initiator caspase of the apoptosis signaling pathway, CASP9 can activate downstream executioner caspases, which involves cleavage of the signaling molecules executioner CASP3, and the apoptotic substrate PARP. CASP3 and PARP levels are an indirect indication of the status of CASP9 activity. 12 In the p.Y251C variant, we found that the levels of cleaved-CASP3 and cleaved-PAPR were significantly attenuated compared with WT (P < 0.05; Figure 3A) ; proprotein levels were not altered. Furthermore, CASP3 activity in the p.Y251C vari- 
| The p.R191G and p.Y251C variants inhibited low (FA)-induced apoptosis
Given epidemiological studies indicate low maternal serum folate levels in the present NTDs cohort, 30 we therefore assayed the local folate concentrations in brain tissues of the NTD cases with CASP9 rare missense variants and matched controls (n = 104). Our data showed that brain tissue folate concentrations were 0.138 ± 0.003 ng/mg in controls. In our previous study, the fetal brain tissue folate concentration in 51 controls was 0.136 ± 0.005 ng/mg, 5 which is similar to our present result. Importantly, in the NTD cases A1586 and A1938, the folate levels were 0.089 and 0.0567 ng/mg, respectively, clearly lower than controls ( Table 2 ). This suggests that folate insufficiency might be an environmental factor in cases carrying the CASP9 rare variants.
To understand the possible interplay of low folate levels and missense mutations, we performed apoptotic function assays in 
| DISCUSSION
Results of animal studies support the hypothesis that Casp9 plays a role in NTC: (i) a null mutation of Casp9 causes fetal mouse brain It is generally known that women with low folate intake during pregnancy have significantly increased risk of carrying a fetus with NTDs. Recently, 2 new aspects of the role of apoptosis in embryo neurulation were put forward: one is that apoptotic cells can affect tissue organization and shape by increasing the tension of surrounding cells in leg disk development and dorsal closure in Drosophila embryos 31, 39 ; the other is that apoptotic cells can eliminate FGF8 producing cells in the anterior neural ridge in mouse embryos, and a reduction in the number of apoptotic cells could lead to abnormal accumulation of FGF8 producing cells, thus disturbing gene expression and resulting in forebrain malformations. 40 Whether the mutations we identified have impacts on these 2 areas deserves further attention.
In summary, we have described rare mutations of the apopto- 
